MiR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2

NeuroMolecular Medicine

Volumn 16, Issue 2, 2014, Pages 517-528

  Shi, Lei ^a   Wang, Zhimin ^b   Sun, Guan ^c   Wan, Yi ^b   Guo, Jun ^c   Fu, Xingli ^a  

^a JIANGSU UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

ABCG2; Glioma stem cells; Invasion; Migration; miR 145

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; GELATINASE A; GELATINASE B; MICRORNA 145; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; MICRORNA; MIRN145 MICRORNA, HUMAN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; RNA; SMALL INTERFERING RNA; TUMOR PROTEIN;

ABCG2 GENE; ADULT; ARTICLE; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC CORRELATION; GENETIC REGULATION; GLIOMA CELL; GLIOMA STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIGRATION INHIBITION; MMP 2 GENE; MMP 9 GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; STEM CELL; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; ASTROCYTE; BIOSYNTHESIS; BRAIN TUMOR; CANCER STEM CELL; CELL MOTION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GLIOBLASTOMA; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; REPORTER GENE; RNA INTERFERENCE; TUMOR CELL CULTURE; TUMOR INVASION; XENOGRAFT;

ANIMALS; ASTROCYTES; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN NEOPLASMS; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GLIOBLASTOMA; HETEROGRAFTS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; RNA INTERFERENCE; RNA, NEOPLASM; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 84901283474     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-014-8305-y     Document Type: Article

References (36)

1. Adammek, M., Greve, B., Kässens, N., Schneider, C., Brüggemann, K., Schüring, A.N., et al. (2013) MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors. Fertility and sterility 99(5), 1346-1355.e5.
2. Alison, M. R., Islam, S., & Wright, N. A. (2010). Stem cells in cancer: Instigators and propagators? Journal of Cell Science, 123(Pt 14), 2357-2368.
3. Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756-760.
4. Beier, D., Röhrl, S., Pillai, D. R., Schwarz, S., Kunz-Schughart, L. A., Leukel, P., et al. (2008). Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Research, 68(14), 5706-5715.
5. Bhatia, P., Bernier, M., Sanghvi, M., Moaddel, R., Schwarting, R., Ramamoorthy, A., et al. (2012). Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells. Xenobiotica, 42(8), 748-755.
6. Bise, R., Kanade, T., Yin, Z., & Huh, S. I. (2011). Automatic cell tracking applied to analysis of cell migration in wound healing assay. IEEE Conference Proceedings of Engineering in Medicine Biology Society, 2011, 6174-6179.
7. Bleau, A. M., Hambardzumyan, D., Ozawa, T., Fomchenko, E. I., Huse, J. T., Brennan, C. W., et al. (2009). PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell, 4(3), 226-235.
8. Campayo, M., Navarro, A., Viñolas, N., Diaz, T., Tejero, R., Gimferrer, J. M., et al. (2013). Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer. European Respiratory Journal, 41(5), 1172-1178.
9. Chen, Z., Liu, F., Ren, Q., Zhao, Q., Ren, H., Lu, S., et al. (2010). Suppression of ABCG2 inhibits cancer cell proliferation. International Journal of Cancer, 126(4), 841-851.
10. Chiou, S. H., Yu, C. C., Huang, C. Y., Lin, S. C., Liu, C. J., Tsai, T. H., et al. (2008). Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clinical Cancer Research, 14, 4085-4095.
11. Darling, J. L. (1990). The in vitro biology of human brain tumors. In D. G. T. Thomas (Ed.), Neuro-oncology: Primary malignant brain tumors (pp. 1-25). Baltimore Md: Johns Hopkins University Press.
12. Fillmore, H. L., VanMeter, T. E., & Broaddus, W. C. (2001). Membrane-type matrix metalloproteinases (MT-MMPs): Expression and function during glioma invasion. Journal of Neuro-oncology, 53(2), 187-202.
13. Haapa-Paananen, S., Chen, P., Hellström, K., Kohonen, P., Hautaniemi, S., Kallioniemi, O., et al. (2013). Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation. PLoS One, 8(4), e60930.
14. Ho, M. M., Ng, A. V., Lam, S., & Hung, J. Y. (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Research, 67, 4827-4833.
15. Jia, J., Tian, Q., Ling, S., Liu, Y., Yang, S., & Shao, Z. (2013). miR-145 suppresses osteogenic differentiation by targeting Sp7. FEBS Letters, 587(18), 3027-3031.
16. Jin, Y., Bin, Z. Q., Qiang, H., Liang, C., Hua, C., Jun, D., et al. (2009). ABCG2 is related with the grade of glioma and resistance to mitoxantrone, a chemotherapeutic drug for glioma. Journal of Cancer Research and Clinical Oncology, 135(10), 1369-1376.
17. Lee, H. K., Bier, A., Cazacu, S., Finniss, S., Xiang, C., Twito, H., et al. (2013). MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. PLoS One, 8(2), e54652.
18. Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120(1), 15-20.
19. Li, W. Q., Li, Y. M., Tao, B. B., Lu, Y. C., Hu, G. H., Liu, H. M., et al. (2010). Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance. Medical Science Monitor, 16(10), HY27-HY30.
20. Lu, Y., Chopp, M., Zheng, X., Katakowski, M., Buller, B., & Jiang, F. (2013). MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells. Oncology Reports, 29(1), 67-72.
21. Mohan, A., Kandalam, M., Ramkumar, H. L., Gopal, L., & Krishnakumar, S. (2006). Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma. British Journal of Ophthalmology, 90, 889-893.
22. Okamoto, A., Chikamatsu, K., Sakakura, K., Hatsushika, K., Takahashi, G., & Masuyama, K. (2009). Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncology, 45, 633-639.
23. Omran, O. M. (2012). The prognostic value of breast cancer resistance protein (BCRB/ABCG2) expression in breast carcinomas. Journal of Environmental Pathology, Toxicology and Oncology, 31(4), 367-376.
24. Pek, J. W., Lim, A. K., & Kai, T. (2009). Drosophila maelstrom ensures proper germline stem cell lineage differentiation by repressing microRNA-7. Developmental Cell, 17, 417-424.
25. Rani, S. B., Rathod, S. S., Karthik, S., Kaur, N., Muzumdar, D., & Shiras, A. S. (2013). MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells. Neuro Oncology, 15(10), 1302-1316.
26. Shi, L., Wan, Y., Sun, G., Gu, X., Qian, C., Yan, W., et al. (2012). Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells. NeuroMolecular Medicine, 14(4), 303-316.
27. Speranza, M. C., Frattini, V., Pisati, F., Kapetis, D., Porrati, P., Eoli, M., et al. (2012). NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget, 3(7), 723-734.
28. Stupp, R., Tonn, J. C., Brada, M., & Pentheroudakis, G. (2010). High-grade malignant glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 21, v190-v193.
29. Wang, F., Xue, X., Wei, J., An, Y., Yao, J., Cai, H., et al. (2010). hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. British Journal of Cancer, 103(4), 567-574.
30. Xia, H., Cheung, W. K., Ng, S. S., Jiang, X., Jiang, S., Sze, J., et al. (2012). Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. Journal of Biological Chemistry, 287(13), 9962-9971.
31. Xiang, L., Su, P., Xia, S., Liu, Z., Wang, Y., Gao, P., et al. (2011). ABCG2 is associated with HER-2 expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma. Diagnostic Pathology, 6, 90.
32. Xu, Q., Liu, L., Qian, X., Chen, Q., Jiang, Y., Li, D., et al. (2012). MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Research, 40, 761-774.
33. Xu, Z. Y., Wang, K., Li, X. Q., Chen, S., Deng, J. M., Cheng, Y., et al. (2013). The ABCG2 transporter is a key molecular determinant of the efficacy of sonodynamic therapy with Photofrin in glioma stem-like cells. Ultrasonics, 53(1), 232-238.
34. Yang, S., Cui, H., Xie, N., Icyuz, M., Banerjee, S., Antony, V. B., et al. (2013). miR-145 regulates myofibroblast differentiation and lung fibrosis. FASEB Journal, 27(6), 2382-2391.
35. Ye, X. Z., Xu, S. L., Xin, Y. H., Yu, S. C., Ping, Y. F., Chen, L., et al. (2012). Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway. Journal of Immunology, 189(1), 444-453.
36. Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A. M., Sampath, J., Morris, J. J., et al. (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature Medicine, 7(9), 1028-1034.